A Parsons

3.1k total citations · 1 hit paper
8 papers, 2.3k citations indexed

About

A Parsons is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Nutrition and Dietetics. According to data from OpenAlex, A Parsons has authored 8 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Cardiology and Cardiovascular Medicine, 2 papers in Physiology and 2 papers in Nutrition and Dietetics. Recurrent topics in A Parsons's work include Nitric Oxide and Endothelin Effects (2 papers), Vitamin C and Antioxidants Research (2 papers) and Blood Pressure and Hypertension Studies (1 paper). A Parsons is often cited by papers focused on Nitric Oxide and Endothelin Effects (2 papers), Vitamin C and Antioxidants Research (2 papers) and Blood Pressure and Hypertension Studies (1 paper). A Parsons collaborates with scholars based in United Kingdom, United States and Norway. A Parsons's co-authors include Nigel Stephens, Matthew A. Brown, Frank J. Kelly, Kevin H. Cheeseman, Peter M. Schofield, Brown Mj, P M Schofield, Sue Monteith, Aroon D. Hingorani and Kevin M. O’Shaughnessy and has published in prestigious journals such as The Lancet, Circulation and European Heart Journal.

In The Last Decade

A Parsons

8 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

1996 1.6k citations Nigel Stephens, A Parsons et al. The Lancet profile →

Peers

Countries citing papers authored by A Parsons

Since Specialization

Citations

This map shows the geographic impact of A Parsons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Parsons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Parsons more than expected).

Fields of papers citing papers by A Parsons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Parsons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Parsons. The network helps show where A Parsons may publish in the future.

Co-authorship network of co-authors of A Parsons

This figure shows the co-authorship network connecting the top 25 collaborators of A Parsons. A scholar is included among the top collaborators of A Parsons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Parsons. A Parsons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer 2022 ·Breast Cancer Research and Treatment ·Patricia A. Ganz, Hanna Bandos, Charles E. Geyer, André Robidoux, Alexander Paterson, Jonathan Polikoff, Luis Báez-Díaz, Adam Brufsky, Louis Fehrenbacher, A Parsons, Patrick J. Ward, Louise Provencher, John Hamm, Philip J. Stella, (unknown), Richard G. Margolese, Henry R. Shibata, Edith A. Perez, Norman Wolmark	1
2	Quantitative neuropathological analysis of Sudden Infant Death Syndrome 2002 ·Child Care Health and Development ·Tahera Ansari, Paul Sibbons, A Parsons, Marco Rossi	6
3	The prognostic value of a normal Tc-99m sestamibi SPECT study in suspected coronary artery disease 1999 ·Journal of Nuclear Cardiology ·Prem Soman, A Parsons, Nayana Lahiri, Avijit Lahiri	41
4	A Common Variant of the Endothelial Nitric Oxide Synthase (Glu²⁹⁸→Asp) Is a Major Risk Factor for Coronary Artery Disease in the UK 1999 ·Circulation ·Aroon D. Hingorani, (unknown), (unknown), (unknown), Sue Monteith, A Parsons, Stephen Haydock, Ruth Hopper, Nigel Stephens, Kevin M. O’Shaughnessy, Matthew A. Brown	439
5	A Variant of the Endothelial Nitric Oxide Synthase Gene is a Risk Factor for Coronary Atherosclerosis 1997 ·Clinical Science ·Aroon D. Hingorani, (unknown), (unknown), A Parsons, (unknown), (unknown), (unknown), (unknown), (unknown)	2
6	Risk Factor Reduction 1996 ·European Heart Journal ·(unknown), Knut Rasmussen, Nigel Stephens, A Parsons, Kevin H. Cheeseman, Frank J. Kelly, (unknown), M. J. Mitchinson	2
7	Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) breakdown → 1996 ·The Lancet ·Nigel Stephens, A Parsons, Matthew A. Brown, Peter M. Schofield, Frank J. Kelly, Kevin H. Cheeseman, (unknown)	1599
8	A Randomised Controlled Trial of Vitamin E in Patients with Coronary Disease: The Cambridge Heart Antioxidant Study (CHAOS) 1996 ·Clinical Science ·(unknown), A Parsons, P M Schofield, (unknown), Brown Mj	248

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact